Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
WHO warns against COVID-19 complacency after Moderna vaccine news
'Right now we are extremely concerned by the surge in cases we are seeing in some countries,' WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
ASIA PACIFIC
Nov 13, 2020
China under pressure to reveal vaccine data after Pfizer success
While Beijing has hailed the progress on its own own COVID-19 vaccines, it has so far yet to back this up with evidence.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Russia says its Sputnik V COVID-19 vaccine is 92% effective
Experts welcomed the news but warned that the results were only based on a small number of trial volunteers who had contracted COVID-19.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Brazil says Chinese vaccine trial can resume after suspension
Brazil health regulator Anvisa on Wednesday allowed resumption of late-stage Brazilian clinical trials for China's Sinovac COVID-19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide.
Japan Times
WORLD
Nov 11, 2020
Brazil halts trial of Chinese vaccine. But was science or politics to blame?
Brazil's health regulator provided little information on its decision to suspend the trial, including whether a reported adverse reaction was related to the vaccine.
Japan Times
WORLD / Science & Health / FOCUS
Nov 10, 2020
Why Pfizer’s vaccine won't be at the local pharmacy anytime soon
The vaccine's complex and supercold storage requirements are an obstacle for even the most sophisticated hospitals and may impact when and where it is available.
Japan Times
WORLD / Science & Health
Nov 10, 2020
China vaccine trial halted in Brazil after serious adverse event
The final-stage trial of a Chinese front-runner vaccine candidate has been halted in Brazil due to a serious adverse event, the first time that any of the Asian nation’s rapidly developed COVID-19 shots have met with such a setback.
Japan Times
WORLD / Science & Health
Nov 10, 2020
Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle
The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.
Japan Times
COMMENTARY / World
Nov 7, 2020
The potential for a policy failure on vaccines is huge
Leaders must make decisions about who will get a coronavirus shot first and provide adequate explanations to those denied the vaccine.
Japan Times
WORLD / Science & Health
Nov 4, 2020
Oxford COVID-19 vaccine trial results due this year but not there yet, trial chief says
A vaccine that works is seen as a game-changer in the battle against the coronavirus, which has killed more than 1.2 million people worldwide.
Japan Times
ASIA PACIFIC / Science & Health
Nov 4, 2020
China’s race for COVID-19 vaccine raises safety questions
Process has been unhindered by common scientific setbacks being reported by Western rivals, raising questions about how stringently they are vetting potential issues.
Japan Times
JAPAN / Science & Health
Oct 29, 2020
Japan's Shionogi readies COVID-19 vaccine for December trial
The firm plans to put its vaccine candidate into Phase 1 clinical trials in December and shift into Phase 2 by January.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?